| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2021-06-20 23:27:33 UTC |
|---|
| Updated at | 2021-06-30 00:16:11 UTC |
|---|
| NP-MRD ID | NP0041581 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | renieramycin M |
|---|
| Provided By | JEOL Database |
|---|
| Description | Renieramycin M belongs to the class of organic compounds known as isoquinoline quinones. These are isoquinoline derivative with a structure containing a 5,8-dihydroisoquinoline-5,8-dione skeleton. renieramycin M is found in Jorunna funebris and Xestospongia sp.. renieramycin M was first documented in 2017 (PMID: 29061809). Based on a literature review a small amount of articles have been published on renieramycin M (PMID: 32785022) (PMID: 32437173) (PMID: 31527453) (PMID: 28459574). |
|---|
| Structure | [H]\C(=C(\C(=O)OC([H])([H])[C@]1([H])N2[C@@]([H])(C#N)[C@@]3([H])N(C([H])([H])[H])[C@]([H])(C4=C(C(=O)C(=C(OC([H])([H])[H])C4=O)C([H])([H])[H])C3([H])[H])[C@]2([H])C([H])([H])C2=C1C(=O)C(OC([H])([H])[H])=C(C2=O)C([H])([H])[H])C([H])([H])[H])C([H])([H])[H] InChI=1S/C31H33N3O8/c1-8-13(2)31(39)42-12-21-22-16(25(35)14(3)29(40-6)27(22)37)10-19-24-23-17(26(36)15(4)30(41-7)28(23)38)9-18(33(24)5)20(11-32)34(19)21/h8,18-21,24H,9-10,12H2,1-7H3/b13-8-/t18-,19-,20-,21-,24-/m0/s1 |
|---|
| Synonyms | Not Available |
|---|
| Chemical Formula | C31H33N3O8 |
|---|
| Average Mass | 575.6180 Da |
|---|
| Monoisotopic Mass | 575.22677 Da |
|---|
| IUPAC Name | [(1R,2S,10R,12R,13S)-12-cyano-7,18-dimethoxy-6,17,21-trimethyl-5,8,16,19-tetraoxo-11,21-diazapentacyclo[11.7.1.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-4(9),6,15(20),17-tetraen-10-yl]methyl (2Z)-2-methylbut-2-enoate |
|---|
| Traditional Name | [(1R,2S,10R,12R,13S)-12-cyano-7,18-dimethoxy-6,17,21-trimethyl-5,8,16,19-tetraoxo-11,21-diazapentacyclo[11.7.1.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-4(9),6,15(20),17-tetraen-10-yl]methyl (2Z)-2-methylbut-2-enoate |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | [H]\C(=C(\C(=O)OC([H])([H])[C@]1([H])N2[C@@]([H])(C#N)[C@@]3([H])N(C([H])([H])[H])[C@]([H])(C4=C(C(=O)C(=C(OC([H])([H])[H])C4=O)C([H])([H])[H])C3([H])[H])[C@]2([H])C([H])([H])C2=C1C(=O)C(OC([H])([H])[H])=C(C2=O)C([H])([H])[H])C([H])([H])[H])C([H])([H])[H] |
|---|
| InChI Identifier | InChI=1S/C31H33N3O8/c1-8-13(2)31(39)42-12-21-22-16(25(35)14(3)29(40-6)27(22)37)10-19-24-23-17(26(36)15(4)30(41-7)28(23)38)9-18(33(24)5)20(11-32)34(19)21/h8,18-21,24H,9-10,12H2,1-7H3/b13-8-/t18-,19-,20-,21-,24-/m0/s1 |
|---|
| InChI Key | QOGBZZDZYZICFV-NZDGDHNMSA-N |
|---|
| Experimental Spectra |
|---|
|
| | Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 500 MHz, CDCl3, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, CDCl3, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 100 MHz, CDCl3, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, CDCl3, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 200 MHz, CDCl3, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, CDCl3, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 300 MHz, CDCl3, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, CDCl3, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 400 MHz, CDCl3, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, CDCl3, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 600 MHz, CDCl3, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, CDCl3, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 700 MHz, CDCl3, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, CDCl3, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 800 MHz, CDCl3, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, CDCl3, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 900 MHz, CDCl3, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, CDCl3, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, CDCl3, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, CDCl3, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Predicted Spectra |
|---|
|
| Not Available | | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | | Species Name | Source | Reference |
|---|
| Jorunna funebris | LOTUS Database | | | Xestospongia sp. | JEOL database | - Tatsukawa, M., et al, Tetrahedron, 68, 7422 (2012)
|
|
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as isoquinoline quinones. These are isoquinoline derivative with a structure containing a 5,8-dihydroisoquinoline-5,8-dione skeleton. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Isoquinolines and derivatives |
|---|
| Sub Class | Isoquinoline quinones |
|---|
| Direct Parent | Isoquinoline quinones |
|---|
| Alternative Parents | |
|---|
| Substituents | - Isoquinoline quinone
- Isoquinolone
- Fatty acid ester
- N-methylpiperazine
- N-alkylpiperazine
- 1,4-diazinane
- Piperazine
- Fatty acyl
- Vinylogous ester
- Alpha,beta-unsaturated carboxylic ester
- Enoate ester
- Amino acid or derivatives
- Alpha-aminonitrile
- Tertiary aliphatic amine
- Tertiary amine
- Carboxylic acid ester
- Ketone
- Azacycle
- Carboxylic acid derivative
- Monocarboxylic acid or derivatives
- Carbonitrile
- Nitrile
- Cyanide
- Organic oxygen compound
- Organic nitrogen compound
- Amine
- Organooxygen compound
- Organic oxide
- Carbonyl group
- Hydrocarbon derivative
- Organonitrogen compound
- Aliphatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aliphatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - Chamni S, Sirimangkalakitti N, Chanvorachote P, Suwanborirux K, Saito N: Chemistry of Renieramycins. Part 19: Semi-Syntheses of 22-O-Amino Ester and Hydroquinone 5-O-Amino Ester Derivatives of Renieramycin M and Their Cytotoxicity against Non-Small-Cell Lung Cancer Cell Lines. Mar Drugs. 2020 Aug 10;18(8). pii: md18080418. doi: 10.3390/md18080418. [PubMed:32785022 ]
- Zheng Y, Li XD, Sheng PZ, Yang HD, Wei K, Yang YR: Asymmetric Total Syntheses of (-)-Fennebricin A, (-)-Renieramycin J, (-)-Renieramycin G, (-)-Renieramycin M, and (-)- Jorunnamycin A via C-H Activation. Org Lett. 2020 Jun 5;22(11):4489-4493. doi: 10.1021/acs.orglett.0c01493. Epub 2020 May 21. [PubMed:32437173 ]
- Tun JO, Salvador-Reyes LA, Velarde MC, Saito N, Suwanborirux K, Concepcion GP: Synergistic Cytotoxicity of Renieramycin M and Doxorubicin in MCF-7 Breast Cancer Cells. Mar Drugs. 2019 Sep 16;17(9). pii: md17090536. doi: 10.3390/md17090536. [PubMed:31527453 ]
- Maiuthed A, Pinkhien T, Chamni S, Suwanborirux K, Saito N, Petpiroon N, Chanvorachote P: Apoptosis-inducing Effect of Hydroquinone 5-O-Cinnamoyl Ester Analog of Renieramycin M on Non-small Cell Lung Cancer Cells. Anticancer Res. 2017 Nov;37(11):6259-6267. doi: 10.21873/anticanres.12077. [PubMed:29061809 ]
- Chamni S, Sirimangkalakitti N, Chanvorachote P, Saito N, Suwanborirux K: Chemistry of Renieramycins. 17. A New Generation of Renieramycins: Hydroquinone 5-O-Monoester Analogues of Renieramycin M as Potential Cytotoxic Agents against Non-Small-Cell Lung Cancer Cells. J Nat Prod. 2017 May 26;80(5):1541-1547. doi: 10.1021/acs.jnatprod.7b00068. Epub 2017 May 1. [PubMed:28459574 ]
- Tatsukawa, M., et al. (2012). Tatsukawa, M., et al, Tetrahedron, 68, 7422 (2012). Tetrahedron.
|
|---|